marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 03-03-2025
Ocular Therapeutix Financial Ratios 2011-2025 | OCUL
Annual Financial Ratios Ocular Therapeutix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.9 | -9.6 | -6.1 | -81.3 | -8.1 | -2.3 | -2.4 | -2.7 | -3.6 | -3.6 | -11.3 | - | - | - |
P/S |
14.7 | 13.3 | 8.4 | 12.2 | 72.3 | 47.0 | 73.0 | 88.3 | 84.7 | 81.3 | 420.6 | - | - | - |
EPS |
-1.2 | -1.0 | -0.9 | -0.1 | -2.6 | -1.9 | -1.6 | -2.2 | -1.8 | -1.7 | -2.7 | -5.1 | -5.6 | - |
EV (Enterprise Value) |
689 M | 742 M | 444 M | 485 M | 1.22 B | 227 M | 128 M | 157 M | 150 M | 132 M | 307 M | -13.2 M | -17.8 M | - |
EBITDA per Share |
-1.06 | -0.99 | -1 | -0.99 | -0.99 | -1.84 | -1.49 | -2.09 | -1.71 | -1.61 | -2.49 | - | - | - |
EV/EBITDA |
-5.4 | -18.4 | -2.3 | -2.0 | -2.4 | -3.4 | -3.4 | -11.4 | - | - | - | |||
PEG |
0.62 | 2.11 | 0.6 | 13.9 | 1.75 | 0.11 | -0.08 | 0.12 | 0.68 | -0.1 | 0.06 | - | - | - |
P/B |
3.0 | 8.5 | 12.2 | 6.1 | 16.5 | -54.8 | 4.0 | 6.5 | 3.1 | 1.6 | 5.5 | - | - | - |
P/CF |
-7.0 | -11.1 | -7.3 | -8.1 | -23.5 | -2.5 | -2.8 | -2.9 | -4.4 | -4.0 | -14.9 | - | - | - |
ROE % |
-61.36 | -88.59 | -200.79 | -7.45 | -204.53 | 2379.39 | -167.19 | -242.42 | -85.95 | -44.37 | -48.81 | - | - | - |
ROA % |
-42.26 | -32.03 | -47.58 | -3.20 | -59.43 | -109.69 | -82.11 | -114.35 | -59.65 | -36.03 | -36.64 | - | - | - |
ROCE % |
-54.47 | -90.40 | -222.32 | -88.68 | -82.59 | -128.62 | -92.54 | -147.42 | -65.02 | -36.40 | -37.46 | - | - | - |
Current Ratio |
3.2 | 1.6 | 1.3 | 1.8 | 1.4 | 5.0 | 6.1 | 3.2 | 8.4 | 19.9 | 13.0 | - | - | - |
DSO |
167.7 | 148.3 | 150.5 | 140.0 | 155.2 | 220.0 | 36.9 | 42.9 | 48.4 | 40.3 | 155.6 | - | - | - |
DIO |
173.4 | 147.9 | 129.6 | 101.5 | 188.8 | 149.8 | 170.3 | 97.4 | 93.1 | 153.3 | 533.5 | - | - | - |
DPO |
277.8 | 328.7 | 390.5 | 302.4 | 523.7 | 513.0 | 2327.4 | 2852.1 | 1743.4 | 2239.2 | 5278.5 | - | - | - |
Operating Cycle |
341.1 | 296.2 | 280.1 | 241.5 | 344.0 | 369.8 | 207.2 | 140.3 | 141.5 | 193.6 | 689.0 | - | - | - |
Cash Conversion Cycle |
63.3 | -32.5 | -110.4 | -60.9 | -179.7 | -143.3 | -2120.2 | -2711.8 | -1602.0 | -2045.6 | -4589.4 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Ocular Therapeutix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.22 | -0.26 | -0.49 | - | -0.01 | -0.26 | -0.39 | - | -0.31 | -0.24 | -0.16 | - | 0.03 | -0.11 | 0.04 | - | -0.19 | -0.64 | -0.41 | -0.53 | -0.4 | -0.57 | -0.41 | -0.42 | -0.38 | -0.37 | -0.4 | -0.44 | -0.54 | -0.64 | -0.58 | -0.52 | -0.39 | -0.46 | -0.44 | -0.43 | -0.47 | -0.45 | -0.35 | -0.37 | -0.48 | -2.1 | -2.45 | -1.32 | -1.34 | -1.19 | -1.26 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.23 | - | - | - | -0.29 | - | -0.26 | -0.24 | -0.23 | - | -0.23 | -0.25 | -0.26 | - | -0.19 | -0.29 | -0.31 | -0.43 | -0.45 | -0.48 | -0.45 | -0.42 | -0.34 | -0.33 | -0.37 | -0.43 | -0.48 | -0.61 | -0.56 | -0.5 | -0.35 | -0.43 | -0.42 | -0.42 | -0.43 | -0.42 | -0.32 | -0.35 | -0.42 | -1.87 | -2.35 | -1.28 | -1.2 | -1.08 | - | - | - | - | - | - | - | - | - |
ROE % |
-44.42 | -40.63 | -699.01 | -988.74 | -1041.07 | -1086.82 | -445.37 | -96.56 | -93.52 | -38.15 | -20.20 | -3.78 | -19.48 | -38.22 | -75.71 | -92.02 | 624.70 | 1157.70 | 1879.39 | 2379.39 | 1614.17 | 1055.03 | 342.92 | -167.19 | -168.80 | -186.49 | -219.51 | -242.42 | -216.97 | -175.88 | -126.39 | -85.95 | -73.17 | -67.59 | -56.75 | -44.37 | -46.05 | -45.61 | -45.33 | -48.81 | -29.36 | -11.01 | 5.07 | 17.01 | 11.12 | 5.20 | - | - | - | - | - | - | - | - | - |
ROA % |
-28.26 | -21.13 | -29.54 | -40.77 | -56.03 | -70.96 | -64.93 | -32.78 | -31.56 | -15.09 | -7.92 | -1.17 | -5.73 | -11.51 | -21.80 | -26.74 | -59.78 | -79.07 | -96.16 | -109.69 | -100.47 | -97.17 | -85.02 | -82.11 | -81.93 | -89.46 | -104.29 | -114.35 | -107.82 | -92.55 | -74.09 | -59.65 | -52.19 | -49.83 | -43.63 | -36.03 | -36.56 | -35.44 | -34.55 | -36.64 | -44.77 | -53.84 | -61.80 | -52.84 | -34.53 | -16.14 | - | - | - | - | - | - | - | - | - |
ROCE % |
-277.03 | -508.63 | -1163.43 | -1143.21 | -1189.82 | -991.75 | -355.67 | -99.22 | -121.58 | -97.33 | -92.28 | -71.82 | -90.23 | -86.27 | -84.57 | -63.74 | 525.82 | 1181.80 | 1800.32 | 2363.69 | 1725.96 | 1047.08 | 414.26 | -164.79 | -165.25 | -182.06 | -214.39 | -236.83 | -212.17 | -171.82 | -123.04 | -83.31 | -70.79 | -65.50 | -54.90 | -42.64 | -44.02 | -43.10 | -42.47 | -46.16 | -27.55 | -10.23 | 4.92 | 16.55 | 10.80 | 5.03 | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.5 | 3.7 | 4.1 | 1.6 | 1.1 | 1.0 | 1.1 | 1.3 | 1.4 | 1.6 | 1.7 | 1.8 | 1.7 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.0 | 1.0 | 1.0 | 1.0 | 2.0 | 2.0 | 2.0 | 2.0 | 1.9 | 1.9 | 1.9 | 1.9 | 3.3 | 3.3 | 3.3 | 3.3 | 5.3 | 5.3 | 5.3 | 5.3 | 4.0 | 4.0 | 4.0 | 4.0 | 4.5 | 4.5 | 4.5 | - | - | - | - | - | - | - | - | - |
DSO |
178.8 | 157.6 | 162.8 | - | 154.0 | 145.5 | 144.8 | - | 153.6 | 162.5 | 153.4 | - | 143.7 | 126.0 | 160.8 | - | 190.3 | 712.5 | 258.8 | 103.1 | 280.5 | 357.7 | 254.9 | 36.4 | 36.8 | 28.3 | 57.3 | 42.4 | 39.4 | 47.1 | 45.7 | 44.6 | 23.9 | - | 19.2 | 40.0 | 37.5 | 51.3 | 72.9 | 59.5 | 209.9 | 309.5 | 978.4 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
144.7 | 154.8 | 167.9 | - | 147.8 | 156.4 | 159.3 | - | 129.5 | 112.9 | 91.5 | - | 81.3 | 93.0 | 118.9 | - | 243.5 | 817.9 | 120.0 | - | 108.0 | 157.7 | 417.4 | - | 172.2 | 129.4 | 193.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
224.8 | 306.6 | 373.1 | - | 250.4 | 315.4 | 397.0 | - | 383.2 | 281.4 | 281.2 | - | 283.1 | 334.4 | 350.9 | - | 549.3 | 1844.8 | 333.0 | - | 370.0 | 540.2 | 2221.7 | - | 2352.7 | 1768.3 | 3727.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
323.6 | 312.4 | 330.7 | - | 301.8 | 301.9 | 304.2 | - | 283.1 | 275.4 | 244.9 | - | 225.0 | 219.1 | 279.7 | - | 433.8 | 1530.4 | 378.9 | 103.1 | 388.5 | 515.4 | 672.3 | 36.4 | 209.0 | 157.7 | 250.6 | 42.4 | 39.4 | 47.1 | 45.7 | 44.6 | 23.9 | - | 19.2 | 40.0 | 37.5 | 51.3 | 72.9 | 59.5 | 209.9 | 309.5 | 978.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
98.8 | 5.7 | -42.3 | - | 51.4 | -13.4 | -92.9 | - | -100.1 | -6.0 | -36.2 | - | -58.0 | -115.3 | -71.2 | - | -115.5 | -314.4 | 45.9 | 103.1 | 18.5 | -24.8 | -1549.4 | 36.4 | -2143.7 | -1610.6 | -3476.9 | 42.4 | 39.4 | 47.1 | 45.7 | 44.6 | 23.9 | - | 19.2 | 40.0 | 37.5 | 51.3 | 72.9 | 59.5 | 209.9 | 309.5 | 978.4 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency